Baseline characteristics were well balanced, with slightly more cases of high-grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangement in the tisa-cel arm (20% vs. 12%). The gene discussed is BCL6; the disease is B-cell non-Hodgkin lymphoma.